Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation

Autor: Daniel B. Rubinstein, Michel Symann, Thierry Guillaume
Rok vydání: 1998
Předmět:
Zdroj: Blood. 92:1471-1490
ISSN: 1528-0020
0006-4971
DOI: 10.1182/blood.v92.5.1471.417k39_1471_1490
Popis: APPROXIMATELY 10,000 autologous hematopoietic stem cell (HSC) transplants are performed worldwide each year for malignant diseases.[1][1] Results of randomized trials in recent years suggest that high-dose chemotherapy followed by infusion of autologous HSCs can offer prolonged disease-free survival
Databáze: OpenAIRE